The company said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of cancer in which the bone marrow makes too many of certain white blood cells.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment